Comparison of Two Regimens of Anesthesia for Children Undergoing Magnetic Resonance Imaging (MRI) in General Anesthesia

NCT ID: NCT00949507

Last Updated: 2013-05-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of two regimens (Sevorane/LMA ctr. Propofol/Remifentanil) for children undergoing MRI in general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia Children MRI Sevoflurane Propofol/Remifentanil

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

anaesthesia using propofol

the children are anaesthetized using intravenous anaesthesia with propofol and remifentanil; a binasal catheter is used for administration of oxygen during the anaesthesia

No interventions assigned to this group

anaesthesia using sevoflurane

the patients are anaesthetized using sevoflurane 1 MAC; a laryngeal mask is used

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children aged 1 to 10 yrs.
* ASA 1-2

Exclusion Criteria

* Allergy to soya (propofol)
* Allergy to Pentobarbital
* Allergy to Remifentanil
* Allergy to Sevoflurane
* Children undergoing blood tests or further examinations in conjunction with the MRI
* Children with unexplained fever
* Children which are evaluated not to be able to keep a open airway
Minimum Eligible Age

1 Year

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Niels Anker Pedersen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Niels Anker Pedersen

MD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Glostrup University Hospital, Dept. of Anesthesia

Glostrup Municipality, Copenhagen, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EudraCT 2008-002690-12

Identifier Type: -

Identifier Source: secondary_id

2008-41-2609

Identifier Type: -

Identifier Source: secondary_id

2612-3762

Identifier Type: -

Identifier Source: secondary_id

H-A-2008-060

Identifier Type: -

Identifier Source: secondary_id

2008-209

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dose of Remimazolam in Children for Intubation
NCT06170918 NOT_YET_RECRUITING NA